FDA Inspection
Clario (BioClinica, Inc.)Clario (BioClinica, Inc.) – FDA Inspection, Oct 11, 2024
Record Details
This FDA Inspection record concerns Clario (BioClinica, Inc.), with an inspection on October 11, 2024, issued by the Philadelphia District Office, covering human drugs.
View Company Profile
ID · 9fd53650-a503-45f3-ba74-7bb987871ff6
Inspection Facts
- Inspection number
- 1256108
- FDA center
- Human Drugs
Other FDA inspections of Clario (BioClinica, Inc.)
13| Date | Classification | Office | Project area |
|---|---|---|---|
| August 18, 2026 | Not classified | Philadelphia District Office | |
| July 30, 2026 | Not classified | Philadelphia District Office | |
| June 25, 2026 | Not classified | Philadelphia District Office | |
| April 22, 2026 | Not classified | Philadelphia District Office | |
| February 23, 2026 | Not classified | Philadelphia District Office |
Other documents for Clario (BioClinica, Inc.)
- FDA Inspection 1334408 - 2026-08-18
- FDA Inspection 1330718 - 2026-07-30
- FDA Inspection 1325092 - 2026-06-25
- FDA Inspection 1318274 - 2026-04-22
- FDA Inspection 1314940 - 2026-02-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.